Evidence map›Paper›PMID 39444814›Full record

SynthesisFrontiers in medicine2024

Trends and hotspots in the field of diabetic retinopathy imaging research from 2000-2023.

Qing Zhang, Ping Zhang, Naimei Chen, Zhentao Zhu, Wangting Li, Qiang Wang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qing Zhang *The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang Medical University, Xinxiang, China.
Ping Zhang *Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Naimei ChenDepartment of Ophthalmology, Huaian Hospital of Huaian City, Huaian, China.
Zhentao ZhuDepartment of Ophthalmology, Huaian Hospital of Huaian City, Huaian, China.
Wangting LiShenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, China.
Qiang WangDepartment of Ophthalmology, Third Affiliated Hospital, Wenzhou Medical University, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diabetic retinopathy (DR) poses a major threat to diabetic patients' vision and is a critical public health issue. Imaging applications for DR have grown since the 21st century, aiding diagnosis, grading, and screening. This study uses bibliometric analysis to assess the field's advancements and key areas of interest. Methods: This study performed a bibliometric analysis of DR imaging articles collected from the Web of Science Core Collection database between January 1st, 2000, and December 31st, 2023. The literature information was then analyzed through CiteSpace. Results: The United States and China led in the number of publications, with 719 and 609, respectively. The University of London topped the institution list with 139 papers. Tien Yin Wong was the most prolific researcher. Invest. Ophthalmol. Vis. Sci. published the most articles (105). Notable burst keywords were "deep learning," "artificial intelligence," et al. Conclusion: The United States is at the forefront of DR research, with the University of London as the top institution and Invest. Ophthalmol. Vis. Sci. as the most published journal. Tien Yin Wong is the most influential researcher. Hotspots like "deep learning," and "artificial intelligence," have seen a significant rise, indicating artificial intelligence's growing role in DR imaging.

Indexed as

artificial intelligencebibliometricdiabetic retinopathydiagnosisimaging

Identifiers

PMID39444814
PMCPMC11496202

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.